Legend Biotech (LEGN) Other Non-Current Liabilities (2020 - 2026)
Legend Biotech (LEGN) posted Other Non-Current Liabilities of $7.7 million for Q2 2026, down 1.3% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Legend Biotech's Other Non-Current Liabilities came in at $8 million, up 31.1% from FY2024.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 70.6% (FY2020 to FY2025).
- In prior years, Legend Biotech's Other Non-Current Liabilities was $6.1 million in FY2024, $56,000 in FY2023 (-76.0%), $233,000 in FY2022 (-41.2%) and $396,000 in FY2021 (-28.5%).
- The Q2 2026 figure stands as the lowest quarterly Other Non-Current Liabilities since Q4 2024.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q4 2025, with growth of 31.1%; the weakest was Q1 2024, with a decline of 86.6%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $7.8 million (Q1 2026), $8 million (Q4 2025) and $8.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Legend Biotech | 3.49 Bn | 986.33 Mn | 251.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.70 Mn |
| Mar 31, 2026 | 7.80 Mn |
| Dec 31, 2025 | 8.00 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Dec 31, 2024 | 6.15 Mn |
| Sep 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 152,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Dec 31, 2022 | 233,000.00 |
| Mar 31, 2022 | 356,000.00 |
| Dec 31, 2021 | 396,000.00 |
| Sep 30, 2021 | 991,000.00 |
| Jun 30, 2021 | 554,000.00 |
| Mar 31, 2021 | 554,000.00 |
| Dec 31, 2020 | 554,000.00 |
API Access
Legend Biotech Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();